CompletedNCT01397864
C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pharming Technologies B.V.
- Principal Investigator
- Anurag Relan, MDPharming Technologies BV
- Intervention
- rhC1INH or pdC1INH(drug)
- Enrollment
- 181 enrolled
- Eligibility
- All sexes
- Timeline
- 2011 – 2024
Study locations (17)
- UMHAT Alexandrovska EAD, Sofia, Bulgaria
- KBC Split, Split, Croatia
- General Hospital Sibenik, Šibenik, Croatia
- CHC Sestre milosrdnice, Zagreb, Croatia
- Faculty Hospital by St. Anna Brno, Brno, Czechia
- Hospital A Michallon, CHU Grenoble, La Tronche, France
- Charite Universitatsmedizin Berlin, Berlin, Germany
- Semmelweis University, 3rd Department of Internal Medicine, Budapest, Hungary
- Ospedale Luigi Sacco, Milan, Italy
- PHI University Clinic of Dermatology, Skopje, North Macedonia
- Alesund Hospital, Ålesund, Norway
- Stavanger University Hospital, Stavanger, Norway
- University Hospital Krakow, Krakow, Poland
- Bratislava University Hospital, Bratislava, Slovakia
- University Hospital Martin, Martin, Slovakia
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01397864 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.